Total Return chart Lineage Cell Therapeutics, Inc.
Stocks
LCTX
US53566P1093
Biotechnology & Medical Research
|
Market Closed -
NYSE
21:00:00 16/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 0.9783 USD | -1.21% |
|
-1.58% | -41.42% |
| 09-30 | EARNINGS: Generation Essentials interim profit jumps to USD28 million | AN |
| 08-07 | Lineage Cell Therapeutics, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
- Stock Market
- Stocks
- LCTX Stock
- Charts Lineage Cell Therapeutics, Inc.
- Total Return chart
Select your edition
All financial news and data tailored to specific country editions
